Your browser is old and is not supported. Upgrade for better security.

Invest in BioSuperior Technology, Inc.

Creating Life Saving Therapeutics For Serious Lung Disease

Highlights

1
Our first treatment is for serious lung illness. It is designed to keep patients off ventilators and out of the ICU.
2
Our drug candidate has worked in animal models. It saves over 50% of animals that have serious lung infection.
3
Our drug candidate is based on 20 years of scientific research.
4
We have been awarded $300k from the March of Dimes
5
We have patents pertaining to our core technologies: US Patent 8,240,080, and, BioST-002.P2, filed October 16, 2020.
6
We are collaborating closely with Columbia University and National Jewish Health scientists
7
Our team includes 4 scientists with about 100 years of cumulative industrial experience.
8
Collectively, we have authored 11 patents, 100 peer reviewed publications, and 7 book chapters.

Our Team

We have seen family members experience serious life challenges or even death as a result of Acute Respiratory Distress Syndrome and other serious respiratory diseases. We are deeply concerned with the standard of care in respiratory medicine and believe that we can substantively improve this situation.

Pitch

Overview